Durability of CNS disease control in NSCLC patients with brain metastases treated with immune checkpoint inhibitors plus cranial radiotherapy-Reference-Cited by-同舟云学术

Durability of CNS disease control in NSCLC patients with brain metastases treated with immune checkpoint inhibitors plus cranial radiotherapy

Published:2021-06 Issue: Volume:156 Page:76-81
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Lau Sally C.M.^ORCID,Poletes Christopher^ORCID,Le Lisa W.,Mackay Kate M.^ORCID,Fares Aline Fusco,Bradbury Penelope A.,Shepherd Frances A.,Tsao Ming Sound^ORCID,Leighl Natasha B.,Liu Geoffrey,Shultz David^ORCID,Sacher Adrian G.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference26 articles.

1. Immune checkpoint inhibitors for the treatment of Central Nervous System (CNS) metastatic disease;Kamath;Front. Oncol.,2018

2. Immune checkpoint blockade - how does it work in brain metastases?;Lorger;Front. Mol. Neurosci.,2019

3. Current approaches to the management of brain metastases;Suh;Nat. Rev. Clin. Oncol.,2020

4. Targeted therapy for brain metastases in EGFR-mutated and ALK-rearranged non-small-cell lung cancer;Baik;J. Thorac. Oncol.,2015

5. Alectinib versus Crizotinib in untreated ALK-positive non–small-cell lung cancer;Peters;N. Engl. J. Med.,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. G-CSF improving combined whole brain radiotherapy and immunotherapy prognosis of non-small cell lung cancer brain metastases;International Immunopharmacology;2024-03

2. Immune checkpoint inhibitors for the treatment of non-small cell lung cancer brain metastases;Chinese Medical Journal;2023-04-27

3. Efficacy of different therapies for brain metastases of non-small cell lung cancer: a systematic review and meta-analysis;Translational Lung Cancer Research;2023-04

4. Efficacy of Chemoimmunotherapy in NSCLC Patients With Brain Metastasis With or Without Prior Brain Radiotherapy;Anticancer Research;2022-10

5. International consensus on radiotherapy in metastatic non-small cell lung cancer;Translational Lung Cancer Research;2022-09